Minimally invasive neurosurgery devices sales will rise through 2036, driven by surgical devices at 64.7% of the device type segment in 2026, supported by endoscopic neurosurgery instrument demand and stereotactic system adoption. The market was valued at USD 3.61 billion in 2025 and is expected to be worth USD 7.07 billion by 2036.